Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
CGI	GIB	22. nov 2024	111.60	-0.33
Chain Bridge Bancorp	CBNA	22. nov 2024	24.50	0.00
Chain Bridge I SPAC A	CBRG	22. nov 2024	11.49	0.00
Chain Bridge I Units	CBRGU	22. nov 2024	11.26	0.00
Champion Homes	SKY	22. nov 2024	102.10	+2.02
Champions Oncology	CSBR	22. nov 2024	4.55	+6.56
ChampionX	CHX	22. nov 2024	31.24	-0.13
Channel Therapeutics	CHRO	22. nov 2024	0.66	+4.56
Chanson International	CHSN	22. nov 2024	7.50	+4.17
ChargePoint	CHPT	22. nov 2024	1.15	+1.77
Charles & Colvard	CTHR	22. nov 2024	1.30	-1.88
Charles River Laboratories International	CRL	22. nov 2024	195.77	+0.81
Charles Schwab	SCHW	22. nov 2024	81.26	+0.57
Charlton Aria Acquisition Unit	CHARU	22. nov 2024	9.99	0.00
Chart Industries	GTLS-B	22. nov 2024	69.90	+5.00
Chart Industries	GTLS	22. nov 2024	183.80	+4.38
Charter Communications A	CHTR	22. nov 2024	388.27	+1.15
Chatham Lodging Trust (REIT) A Pref	CLDT-A	22. nov 2024	23.53	-0.04
Chatham Lodging Trust REIT	CLDT	22. nov 2024	9.21	+1.54
Cheche Group	CCG	22. nov 2024	0.87	-0.46
Check Point Software Technolgies	CHKP	22. nov 2024	181.75	-0.13
Check-Cap	CHEK	22. nov 2024	0.82	+1.48
Checkpoint Therapeutics	CKPT	22. nov 2024	3.75	+8.07
Cheer Holding	CHR	22. nov 2024	2.45	-4.30
Cheetah Mobile ADR	CMCM	22. nov 2024	4.55	-1.30
Cheetah Net Supply Chain Service	CTNT	22. nov 2024	1.86	-3.63
Chegg	CHGG	22. nov 2024	2.01	+11.67
Chemed	CHE	22. nov 2024	570.96	+1.36
Chemomab Therapeutics ADR	CMMB	22. nov 2024	1.65	+3.13
Chemours	CC	22. nov 2024	21.53	+3.51

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.